Recent Updates
Recently added Catalysts
IRWD Positive Sentiment

Ironwood Pharmaceuticals to Host Second Quarter 2023 Investor Update Call

Tuesday, July 25, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Ironwood Pharmaceuticals has announced that it will host an investor update call for the second quarter of 2023. This call aims to provide insights into the company's performance and future plans. Such updates are crucial for maintaining investor relations and transparency in the biopharma sector.
Price reaction · baseline $10.75 (2023-07-24 close) · hit after-hours · clean, no other IRWD news in the window
day 0 close · peak
-2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Ironwood Pharmaceuticals is actively engaging with investors.
  • The company is committed to transparency and communication.
  • The update call indicates ongoing progress and developments.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+57%
120-day peak, hindsight
Typical move
3.8%
average across 2 past catalysts
Lead asset
IW-3718
Phase 3 · Gastroesophageal Reflux Disease (GERD)

Full Press Release Details

• Company Company Overview Leadership Open Payments & Transparency
• Science & Medicine Therapeutic Focus Pipeline Product
• Patients Overview
• Responsibility Overview Diversity, Equity & Inclusion Sustainability Safety & Compliance Patients & Research Community Giving
• Careers Working at Ironwood Internships, Co-ops and Fellowships Open Positions
• Investors & Media Contact Us
• Company Overview
• Leadership
• Open Payments & Transparency
• Therapeutic Focus
• Pipeline
• Product
• Overview
• Overview
• Diversity, Equity & Inclusion
• Sustainability
• Safety & Compliance
• Patients & Research
• Community Giving
• Working at Ironwood
• Internships, Co-ops and Fellowships
• Open Positions
• Investors & Media
• Contact Us

Frequently Asked Questions

What is the purpose of the investor update call?

The call aims to provide insights into Ironwood's performance and future plans.

When will the investor update call take place?

The specific date and time for the Q2 2023 investor update call have not been provided.

Who can attend the investor update call?

The call is intended for investors and stakeholders interested in Ironwood Pharmaceuticals.

ShareAdd on Google
Tags: IRWD Viatris Investor Conferences Healthcare Ironwood Pharmaceuticals investor update Q2 2023 biopharma
Last updated: Jul 25, 2023

Biotech snapshot

Cash runway
$79M liquidity · $0M/mo burn
Low dilution risk
Lead asset
IW-3718Phase 3
Gastroesophageal Reflux Disease (GERD) →

Catalyst track record

+57%
best trade around IRWD's most recent catalyst

Peak hindsight return over a 120-day window, across 2 tracked FDA/PDUFA catalysts for IRWD.

See every catalyst's timing & PoA →